CSIMarket
 
Beyondspring Inc   (BYSI)
Other Ticker:  
 
 
Price: $2.8800 $-0.06 -2.041%
Day's High: $3.0499 Week Perf: -4.32 %
Day's Low: $ 2.75 30 Day Perf: 110.22 %
Volume (M): 247 52 Wk High: $ 4.00
Volume (M$): $ 710 52 Wk Avg: $1.10
Open: $2.92 52 Wk Low: $0.65



 Market Capitalization (Millions $) 113
 Shares Outstanding (Millions) 39
 Employees -
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -36
 Cash Flow (TTM) (Millions $) -7
 Capital Exp. (TTM) (Millions $) 0

Beyondspring Inc
Beyondspring Inc is a clinical-stage pharmaceutical company that focuses on the development of innovative cancer therapies. The company is involved in discovering and developing novel immuno-oncology drugs to improve the outcomes of cancer patients. Beyondspring's drug candidates are designed to target specific mechanisms within the immune system to enhance anti-cancer response and reduce the relapse rate. Their flagship product, Plinabulin, has shown promising results in clinical trials for the treatment of various types of cancers, including non-small cell lung cancer and triple-negative breast cancer. Beyondspring Inc is dedicated to bringing new treatment options to patients and improving cancer care worldwide.


   Company Address: 28 Liberty Street, 39th Floor New York 10005 NY
   Company Phone Number: 305-6387   Stock Exchange / Ticker: NASDAQ BYSI
   BYSI is expected to report next financial results on April 17, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Stock Market Announcement

BeyondSpring Faces Nasdaq Delinquency Notice: A Critical Moment for the Clinical-stage Biopharmaceutical Company

Published Wed, Jan 10 2024 8:00 PM UTC

BeyondSpring Inc., a global clinical-stage biopharmaceutical company, recently announced that it received a Foreign Delinquency Compliance Plan Alert Letter from The Nasdaq Stock Market LLC. This letter notified the company that it is not in compliance with Nasdaq Listing Rule 5250(c)(2) due to its failure to timely file its Form 6-K for the period ended June 30, 2023.
T...






 

Beyondspring Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com